Biota Pharma (BOTA) Posts Surprise Q2 Profit

Biota Pharma (NASDAQ: BOTA) reported Q2 EPS of $0.19, $0.28 better than the analyst estimate of ($0.09). Revenue for the quarter came in at $13.9 million versus the consensus estimate of $7.4 million.

For earnings history and earnings-related data on Biota Pharma (BOTA) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Newton Golf Company (NWTG) Reports Q2 Loss of $0.49
• Hydrofarm Holdings Group, Inc. (HYFM) Misses Q2 EPS by 134c